私募股权巨头KKR（KKR.US）将以4亿美元的价格从CVC Capital Partners手中收购印度Healthcare Global Enterprises ...

私募巨头KKR（KKR.US）宣布以4亿美元的价格收购印度Healthcare Global Enterprises Ltd.（HCG）多数股权，成为其最大股东与唯一运营商。HCG在声明中表示，KKR将以每股445卢比的价格从CVC Capital Partners手中购买至多54%的股权，随后还将向公众股东公开收购更多股票，最终可能使KKR持有多达77%的股份，全面掌控HCG在印度的业务。

随着阿达尼集团、黑石集团等巨头纷纷布局医疗行业，HCG的收购案背后隐藏着一场全球资本的围猎。在调整资源、追逐利润的过程中，谁将成为这场医药投资游戏的赢家？每张病床背后，都是资本的狂欢，都是无形的博弈。

私募股权机构KKR集团周一宣布，已签署最终协议，将以每股445印度卢比（约合37.20元人民币）的价格收购CVC Asia V机构54%的股份，以此收购印度领先的医疗保健公司Healthcare Global Enterprises（HCG）的多数股权。

KKR将以每股445卢比的价格从CVC Capital Partners手中收购至多54%的HCG股权，并可能通过公开市场向公众股东购买更多股份，最终持有至多77%的HCG股份，实现对HCG在印度业务的全权控制。

HealthCare Global是一家癌症医疗服务提供商，专注于为全球患者提供高质量的医疗服务，提供HCG三级护理医院、肿瘤治疗、儿科和儿童护理等服务。近日，美国私募巨头KKR集团宣布，已同意以4亿美元收购HealthCare ...

KKR & Co Inc. is set to acquire a majority stake in India’s Healthcare Global Enterprises Ltd. from CVC Capital Partners at a ...

US-based investment company KKR has agreed to acquire a stake of up to 54% in Healthcare Global Enterprises (HCG), an ...

Global investment firm KKR has agreed to acquire a controlling stake in Bengaluru-based Healthcare Global Enterprises (HCG) ...

KKR & CVC Asia V reach definitive agreements to become the largest shareholder in HCG for $400M, with SEBI's Takeover ...

KKR acquires a controlling stake in Healthcare Global from CVC Capital Partners for Rs 3466 crore, strengthening its presence ...

KKR will purchase HCG shares at Rs 445 per share and make an open offer for the company's shareholders to buy an additional ...